Public Company News
Recon Technology Announces Pricing of $8 million Registered Direct Offering
BEIJING, March 15, 2023 /PRNewswire/ -- Recon Technology, Ltd. (NASDAQ: RCON) ("Recon" or the "Company") announced today it has entered into a securities purchase agreement with certain accredited investors onMarch 15, 2023 to purchase approximately$8 million worth of its Class A ordinary shares ...
Lunit to Present 5 Abstracts at the 2023 AACR Annual Meeting
* Five posters from Lunit and collaborators demonstrate important progress in the development of novel diagnostics for important cancer therapies, including immunotherapy SEOUL, South Korea, March 15, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer sol...
SK Chemicals to Take the Lead in the $7.6 Billion Recycled PET Market
* Signed a $100 million asset purchase agreement with Shuye of China; secured the world's first mass production system for recycled raw materials and PET * The abundant supply of recycled plastic raw materials enables SK chemicals to have the highest level of price competitiveness and facilita...
Bridge Biotherapeutics to Present Updated Preclinical Data of BBT-207 at the AACR 2023 Annual Meeting
* The abstract of BBT-207 preclinical studies is now available on the AACR
website
Daqo New Energy's Subsidiary Xinjiang Daqo Proposes Cash Dividend Plan for 2022 to Its Annual Shareholders' Meeting For Approval
SHANGHAI, March 15, 2023 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy", the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced that its subsidiary Xinjiang Daqo's board of directors had approved its cash d...
Hyosung Chairman Cho Hyun-joon to achieve competitiveness in the US power market
SEOUL, South Korea, March 15, 2023 /PRNewswire/ -- Hyosung Chairman Cho Hyun -joon has set about acquiring human resources to enhance competitiveness in the US power market, the largest market in the world. The company founded a corporation for manufacturing in the US for local production and is n...
WiMi Hologram Cloud Discloses An XR-Based Human-Computer Interaction System
BEIJING, March 15, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced the development of a human-computer interaction system based on XR. It conducted in-depth research int...
Farmmi Customer Increases Shipments to Lebanon
LISHUI, China, March 15, 2023 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agricultural products supplier inChina, today announced one of its long-term customers is continuing to ramp up its shipments toLebanon with its latest follow-on order for the Company's popul...
HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program
* Applications for physicians trained in Indonesia now open until April 15, 2023 12:00 AM * The Pharmaceutical Industry Fellowship Program provides physicians with the opportunity to experience the various steps of the drug development process ROCKVILLE, Md. and SEOUL, South Korea, March 15, ...
NEW AMAZFIT GTR MINI IS UNVEILED, PACKING MAX POWER & STYLE INTO A SLIM & LIGHT ROUND SMARTWATCH
CUPERTINO, Calif., March 15, 2023 /PRNewswire/ -- Amazfit
DADA Now's Automobile Delivery Service Fulfills 3.3 million orders in 60 cities Across China
SHANGHAI, March 15, 2023 /PRNewswire/ -- The on-demand delivery service platform from Dada Group (Nasdaq: DADA) ("Dada"), Dada Now, has recently launched an automobile delivery service, to better support small and medium enterprises (SMEs). To date, the automobile delivery service has been launc...
Jacobio Pharma to Present Data of Three Preclinical Studies at the 2023 AACR Annual Meeting
BEIJING and SHANGHAI and BOSTON, Mass., March 14, 2023 /PRNewswire/ -- Jacobin Pharma (1167.HK) today announced that the company will present the results of three preclinical studies of KRASmulti inhibitor JAB-23425, CD73-STING iADC JAB-X1800, and Aurora kinase A inhibitor JAB-2485 in form of the...
ICZOOM Group Inc. Announces Pricing of US$6 Million Initial Public Offering
SHENZHEN, China, March 14, 2023 /PRNewswire/ -- ICZOOM Group Inc. (the "Company" or "ICZOOM"), a B2B e-commerce trading platform primarily engaged in sales of electronic component products inHong Kong and mainland China, today announced the pricing of its initial public offering (the "Offering") ...
Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting
SUZHOU, China and ROCKVILLE, Md., March 14, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the latest results from three preclinical s...
FinVolution Group Increases Dividend Payout Ratio to 18.5% for Fiscal Year 2022, with US$0.215 per American Depositary Share
Marks the fifth consecutive year of dividend declarations SHANGHAI, March 14, 2023 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced that its board of directors (the "Board") has approved a cash dividend ofUS$0.215 per A...
FinVolution Group Reports Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results and Announces Management Changes
-International business revenue contribution reached 12.9% of total revenue for the fourth quarter and 10.3% for FY 2022 through Local Focus, Global Outlook Strategy- -2022 Full Year Total Transaction Volume set new record high at RMB175.4 billion, an increase of 27.7% compared to Fiscal Year 20...
Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011
SHANGHAI, March 14, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, launched first in human clinical trial of its iron homeostasis regulating macromolecular drug 9MW3011. The study (CTR20230046) is a phase 1, single cente...
WiMi Develops Digital Twin Visualization and Interaction System to Boost Intelligent Industrial Transformation
BEIJING, March 14, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced the development of its digital twin visualization and interaction system by fusing digital twin, artif...
Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclonal Antibody, in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1 Trial in Advanced Solid Tumors and Cutaneous T-cell Lymphoma
NANJING, China, March 14, 2023 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) (Simcere), an innovative global biopharmaceutical company, announced today that Simcere Zaiming, an innovative oncology pharmaceutical company of Simcere has entered into a clinical collaboration agreeme...
Jianpu Technology Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Tuesday, March 21, 2023
BEIJING, March 14, 2023 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (NYSE: JT), a leading independent open platform for discovery and recommendation of financial products inChina, today announced that it will report its fourth quarter and fiscal year 2022 unaudited financi...
Week's Top Stories
Most Reposted
InfoComm Asia 2026 - Asia's Super Connector for Professional AV - Takes Place Next Week in Bangkok
[Picked up by 297 media titles]
2026-07-07 09:00A New Chapter Beckons: Four Seasons Resorts of Asia Celebrates Parenthood with Babymoon Offerings
[Picked up by 293 media titles]
2026-07-10 13:30PropertyGuru Group's 2025 Sustainability Report Reinforces its Commitment to More Resilient and Inclusive Urban Futures Across Southeast Asia
[Picked up by 291 media titles]
2026-07-08 12:09NCS launches enterprise AI platforms and products; deepens partnerships to accelerate AI-driven business transformation
[Picked up by 288 media titles]
2026-07-09 08:00Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
[Picked up by 285 media titles]
2026-07-07 06:00